{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:18:07Z","timestamp":1783149487446,"version":"3.54.6"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSP2145"],"award-info":[{"award-number":["JPMJSP2145"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010067","name":"Government of Arag\u00f3n","doi-asserted-by":"publisher","award":["E34_20R"],"award-info":[{"award-number":["E34_20R"]}],"id":[{"id":"10.13039\/501100010067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007041","name":"Universidad de Zaragoza","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bioorg.2026.109953","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T15:18:57Z","timestamp":1778080737000},"page":"109953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["l-NBDNJ allosteric chaperone for multiple defective enzymes involved in lysosomal storage disorders (LSDs)"],"prefix":"10.1016","volume":"178","author":[{"given":"Anna","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"De Gregorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Montesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Kanekiyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Guaragna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109953_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/35041139","article-title":"Meeting report conformational disease","volume":"2","author":"Kopito","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.109953_bb0010","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0140-6736(97)02073-4","article-title":"Conformational disease","volume":"350","author":"Carrell","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2026.109953_bb0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0014-5793(01)02486-3","article-title":"Protein misfolding and disease","volume":"498","author":"Soto","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioorg.2026.109953_bb0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tem.2004.05.003","article-title":"Pharmacological chaperones: potential treatment for conformational diseases","volume":"15","author":"Bernier","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bioorg.2026.109953_bb0025","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","article-title":"Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases","volume":"21","author":"Soto","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bioorg.2026.109953_bb0030","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2026.109953_bb0035","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer\u2019s disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.bioorg.2026.109953_bb0040","doi-asserted-by":"crossref","first-page":"900","DOI":"10.2174\/0109298665247757231020044633","article-title":"An insight into the protein aggregation in Alzheimer\u2019s disease and its inhibition","volume":"30","author":"Khan","year":"2023","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.bioorg.2026.109953_bb0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1600-0404.2010.01382.x","article-title":"Protein aggregation in Parkinsons disease","volume":"122","author":"Gundersen","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bioorg.2026.109953_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.736978","article-title":"Alpha-Synuclein aggregation in Parkinson\u2019s disease","volume":"8","author":"Srinivasan","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.bioorg.2026.109953_bb0055","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1515\/BC.2000.114","article-title":"Protein aggregation and pathogenesis of Huntington\u2019s disease: mechanisms and correlations","volume":"381","author":"Wanker","year":"2000","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.109953_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2011.12.013","article-title":"Protein aggregates in Huntington\u2019s disease","volume":"238","author":"Arrasate","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bioorg.2026.109953_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.01.017","article-title":"SnapShot: lysosomal storage diseases","volume":"180","author":"Martina","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2026.109953_bb0070","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bioorg.2026.109953_bb0075","series-title":"Encyclopedia of the Neurological Sciences","first-page":"944","article-title":"Lysosomal storage disorders","author":"Pastores","year":"2014"},{"key":"10.1016\/j.bioorg.2026.109953_bb0080","article-title":"The molecular basis for Pompe disease revealed by the structure of human acid \u03b1-glucosidase","author":"Deming","year":"2017","journal-title":"bioRixv"},{"key":"10.1016\/j.bioorg.2026.109953_bb0085","series-title":"GeneReviews\u00ae [Internet]","first-page":"1","article-title":"Glycogen Storage Disease Type II (Pompe Disease)","author":"Leslie","year":"2017"},{"key":"10.1016\/j.bioorg.2026.109953_bb0090","doi-asserted-by":"crossref","first-page":"9462","DOI":"10.1021\/acs.jmedchem.7b00646","article-title":"N-butyl-l-deoxynojirimycin (l-NBDNJ): synthesis of an allosteric enhancer of \u03b1-glucosidase activity for the treatment of Pompe disease","volume":"60","author":"D\u2019Alonzo","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109953_bb0095","series-title":"Lysosomal storage disorders","first-page":"85","article-title":"Gaucher Disease","author":"Elstein","year":"2022"},{"key":"10.1016\/j.bioorg.2026.109953_bb0100","first-page":"8","article-title":"Gaucher disease: Progress and ongoing challenges","volume":"20","author":"Mistry","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bioorg.2026.109953_bb0105","series-title":"Skin and the Heart","first-page":"299","article-title":"Lysosomal storage disorders: Fabry disease","author":"Geenty","year":"2021"},{"key":"10.1016\/j.bioorg.2026.109953_bb0110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ceb.2020.04.002","article-title":"Protein quality control in the endoplasmic reticulum","volume":"65","author":"Phillips","year":"2020","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.109953_bb0115","series-title":"Handbook of experimental pharmacology","first-page":"135","article-title":"Pharmacological chaperones: Beyond conformational disorders","author":"Leidenheimer","year":"2018"},{"key":"10.1016\/j.bioorg.2026.109953_bb0120","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/ijms21020489","article-title":"Pharmacological chaperones: a therapeutic approach for diseases caused by destabilizing missense mutations","volume":"21","author":"Liguori","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.109953_bb0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/adt.2011.0370","article-title":"Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders","volume":"9","author":"Valenzano","year":"2011","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.bioorg.2026.109953_bb0130","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1021\/acschembio.6b00195","article-title":"Pharmacological chaperones: design and development of New therapeutic strategies for the treatment of conformational diseases","volume":"11","author":"Convertino","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.109953_bb0135","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.52586\/5056","article-title":"Role of misfolding in rare enzymatic deficits and use of pharmacological chaperones as therapeutic approach","volume":"26","author":"Pampalone","year":"2021","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.bioorg.2026.109953_bb0140","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1111\/j.1742-4658.2007.06041.x","article-title":"Active-site-specific chaperone therapy for Fabry disease","volume":"274","author":"Fan","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.bioorg.2026.109953_bb0145","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/emmm.200900036","article-title":"Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics","volume":"1","author":"Parenti","year":"2009","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.bioorg.2026.109953_bb0150","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.3390\/molecules25143145","article-title":"Second-generation pharmacological chaperones: beyond inhibitors","volume":"25","author":"Tran","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109953_bb0155","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1039\/C6MB00866F","article-title":"Screening methods for identifying pharmacological chaperones","volume":"13","author":"Shin","year":"2017","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.bioorg.2026.109953_bb0160","series-title":"High-Quality Screening of Pharmacological Chaperones or Enzyme Enhancement Therapy, Diss.","author":"Shanmuganathan","year":"2015"},{"key":"10.1016\/j.bioorg.2026.109953_bb0165","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ijbiomac.2022.12.217","article-title":"Identification of novel glucocerebrosidase chaperone for potential treatment of Parkinson\u2019s disease: an approach using in silico virtual screening, molecular docking and molecular dynamics, and in vitro studies","volume":"228","author":"Tripathi","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2026.109953_bb0170","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1750-1172-6-66","article-title":"Therapy of Fabry disease with pharmacological chaperones: from in silico predictions to in vitro tests","volume":"6","author":"Andreotti","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bioorg.2026.109953_bb0175","doi-asserted-by":"crossref","first-page":"9297","DOI":"10.1039\/C7OB02281F","article-title":"In silico analyses of essential interactions of iminosugars with the Hex A active site and evaluation of their pharmacological chaperone effects for Tay\u2013Sachs disease","volume":"15","author":"Kato","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2026.109953_bb0180","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1021\/acs.jmedchem.2c01617","article-title":"N-substituted l-Iminosugars for the treatment of Sanfilippo type B syndrome","volume":"66","author":"De Pasquale","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109953_bb0185","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","article-title":"Gaucher disease: pathological mechanisms and modern management","volume":"129","author":"Jmoudiak","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bioorg.2026.109953_bb0190","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1651-2227.2008.00656.x","article-title":"Substrate reduction therapy","volume":"97","author":"Platt","year":"2008","journal-title":"Acta Pediatr."},{"key":"10.1016\/j.bioorg.2026.109953_bb0195","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1111\/j.1742-4658.2006.05410.x","article-title":"Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients","volume":"273","author":"Chang","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.bioorg.2026.109953_bb0200","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe\u2019s disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2026.109953_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/humu.1380030102","article-title":"Mutations causing gaucher disease","volume":"3","author":"Horowitz","year":"1994","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bioorg.2026.109953_bb0210","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40291-024-00733-x","article-title":"Advances in Pompe disease treatment: from enzyme replacement to gene therapy","volume":"28","author":"Colella","year":"2024","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.bioorg.2026.109953_bb0215","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1097\/MS9.0000000000002483","article-title":"Pombiliti and Opfolda: shaping the future of adult late-onset pompe disease: an editorial","volume":"86","author":"Riaz","year":"2024","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.bioorg.2026.109953_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020271","article-title":"Fabry disease: molecular basis, pathophysiology, diagnostics and potential therapeutic directions","volume":"11","author":"Kok","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2026.109953_bb0225","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/ph16020320","article-title":"Treatment of Fabry disease: established and emerging therapies","volume":"16","author":"Umer","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.109953_bb0230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejmech.2019.04.061","article-title":"Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease","volume":"175","author":"De Fenza","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109953_bb0235","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1021\/acsptsci.4c00044","article-title":"Assessing the potential of N-butyl-L-deoxynojirimycin (l-NBDNJ) in models of cystic fibrosis as a promising antibacterial agent","volume":"7","author":"Esposito","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.bioorg.2026.109953_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics9060362","article-title":"N-nonyloxypentyl-L-deoxynojirimycin inhibits growth, biofilm formation and virulence factors expression of staphylococcus aureus","volume":"9","author":"De Gregorio","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.bioorg.2026.109953_bb0245","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/md18110572","article-title":"Toward the identification of novel antimicrobial agents: one-pot synthesis of lipophilic conjugates of N-alkyl D-and L-Iminosugars","volume":"18","author":"Esposito","year":"2020","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bioorg.2026.109953_bb0250","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3390\/molecules26061652","article-title":"Synthesis of piperidine nucleosides as conformationally restricted immucillin mimics","volume":"26","author":"De Fenza","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109953_bb0255","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00042560-199510050-00008","article-title":"The tolerability and pharmacokinetics of N-butyl-deoxynojirimycin in patients with advanced HIV disease (ACTG 100)","volume":"10","author":"Tierney","year":"1995","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.bioorg.2026.109953_bb0260","doi-asserted-by":"crossref","DOI":"10.1007\/s11274-022-03310-8","article-title":"The industrial versatility of Gluconobacter oxydans: current applications and future perspectives","volume":"38","author":"da Silva","year":"2022","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.bioorg.2026.109953_bb0265","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1021\/jo800775v","article-title":"Rapid access to 1,6-Anhydro-\u03b2-l-hexopyranose derivatives via domino reaction: synthesis of l-Allose and l-Glucose","volume":"73","author":"D\u2019Alonzo","year":"2008","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2026.109953_bb0270","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1073\/pnas.0605928103","article-title":"The iminosugar isofagomine increases the activity of N370S mutant acid \u03b2-glucosidase in Gaucher fibroblasts by several mechanisms","volume":"103","author":"Steet","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2026.109953_bb0275","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/cbic.200800249","article-title":"Isofagomine induced stabilization of glucocerebrosidase","volume":"9","author":"Kornhaber","year":"2008","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bioorg.2026.109953_bb0280","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nchembio850","article-title":"Structure of acid \u03b2-glucosidase with pharmacological chaperone provides insight into Gaucher disease","volume":"3","author":"Lieberman","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.109953_bb0285","doi-asserted-by":"crossref","DOI":"10.1088\/1742-6596\/1410\/1\/012065","article-title":"Dynamic characteristics of totally glycosylated human glucocerebrosidase carrying N370S substitution","volume":"1410","author":"Cheblokov","year":"2019","journal-title":"J. Phys. Conf. Ser."},{"key":"10.1016\/j.bioorg.2026.109953_bb0290","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1073\/pnas.1818411116","article-title":"Mechanism of glucocerebrosidase activation and dysfunction in Gaucher disease unraveled by molecular dynamics and deep learning","volume":"116","author":"Romero","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2026.109953_bb0295","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.109953_bb0300","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s41467-017-01263-3","article-title":"Structure of human lysosomal acid \u03b1-glucosidase\u2013a guide for the treatment of Pompe disease","volume":"8","author":"Roig-Zamboni","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.109953_bb0305","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/bi9002265","article-title":"Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability \u2020, \u2021","volume":"48","author":"Lieberman","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2026.109953_bb0310","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1248\/cpb.38.882","article-title":"Highly effective resolution of 1,3-dibenzyl-6-hydroxy-3,3a,6,6a-tetrahydro-1H-furo(3,4-d)imidazole-2,4-dione, an intermediate for biotin, with optically active amines and reutilization of the un-wanted epimer","volume":"38","author":"Senuma","year":"1990","journal-title":"Chem. Pharm. Bull. (Tokyo)."},{"key":"10.1016\/j.bioorg.2026.109953_bb0315","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0005-2736(78)90440-6","article-title":"A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Their use in investigating some properties of d-glucose and choline transport systems","volume":"506","author":"Kessler","year":"1978","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.bioorg.2026.109953_bb0320","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.1c01673","article-title":"5 - C - branched Deoxynojirimycin: strategy for designing a 1 - Deoxynojirimycin-based pharmacological chaperone with a nanomolar affinity for Pompe Disease","author":"Kato","year":"2022","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682600489X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682600489X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:43:57Z","timestamp":1783147437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682600489X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":64,"alternative-id":["S004520682600489X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109953","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"l-NBDNJ allosteric chaperone for multiple defective enzymes involved in lysosomal storage disorders (LSDs)","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109953"}}